Hak-Hyun Nam
Gründer bei I-SENS, INC.
Vermögen: 29 Mio $ am 30.04.2024
Aktive Positionen von Hak-Hyun Nam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| I-SENS, INC. | Direktor/Vorstandsmitglied | 04.05.2000 | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | 04.05.2000 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 04.05.2000 | - | |
| Präsident | 31.03.2015 | - | |
| PRECISION BIOSENSOR, INC. | Direktor/Vorstandsmitglied | - | - |
| I Sense Jiangsu Co., Ltd. | Direktor/Vorstandsmitglied | - | - |
CoaguSense, Inc.
 CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Hak-Hyun Nam
Ausbildung von Hak-Hyun Nam
| Michigan State University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Südkorea | 3 |
| China | 2 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| I-SENS, INC. | Health Technology |
| PRECISION BIOSENSOR, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
- Börse
- Insiders
- Hak-Hyun Nam
- Erfahrung
